HomeNews

News

CURE Honors Seven Honorees at MPN Heroes Occasion

CURE Basis honored seven MPN Heroes at its twelfth annual occasion, celebrating their contributions to bettering the lives of sufferers with myeloproliferative neoplasms.CURE®...

Blenrep Combo Accepted for FDA Assessment in R/R A number of Myeloma

The FDA has accepted a biologics license utility for a Blenrep routine for sufferers with relapsed or refractory a number of myeloma.The Meals...

FDA Grants Quick Monitor Designation to R289 in Decrease-Danger MDS

A novel therapy for sufferers with beforehand handled transfusion-dependent low-risk MDS has been granted a quick observe designation by the FDA.The Meals and...

SBRT Could Be Efficient in Managing Intermediate-Danger Prostate Most cancers

An analogous share of sufferers with prostate most cancers had improved most cancers management after receiving five-fraction SBRT versus conventional radiation.Stereotactic physique radiotherapy...

‘Too Younger For Most cancers’ Creator on the Significance of Advocating for Your self

Katie Coleman hopes her story can assist different individuals by means of their most cancers journeys.Coleman, who was identified with a uncommon stage...

Hot Topics